Jane Street’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.11M Buy
31,300
+8,300
+36% +$1.08M ﹤0.01% 4280
2025
Q4
$2.8M Sell
23,000
-32,300
-58% -$4.05M ﹤0.01% 4160
2025
Q3
$6.2M Buy
55,300
+11,600
+27% +$1.36M ﹤0.01% 3092
2025
Q2
$5.86M Buy
43,700
+31,000
+244% +$3.4M ﹤0.01% 2793
2025
Q1
$854K Sell
12,700
-5,800
-31% -$399K ﹤0.01% 5862
2024
Q4
$1.15M Buy
18,500
+6,500
+54% +$605K ﹤0.01% 5104
2024
Q3
$1.88M Buy
12,000
+7,100
+145% +$1.09M ﹤0.01% 4600
2024
Q2
$738K Sell
4,900
-20,300
-81% -$2.43M ﹤0.01% 6353
2024
Q1
$1.86M Buy
25,200
+18,900
+300% +$1.56M ﹤0.01% 4258
2023
Q4
$497K Sell
6,300
-21,000
-77% -$1.27M ﹤0.01% 6761
2023
Q3
$1.49M Buy
27,300
+18,400
+207% +$1.32M ﹤0.01% 4527
2023
Q2
$747K Sell
8,900
-800
-8% -$61.2K ﹤0.01% 5685
2023
Q1
$735K Buy
9,700
+5,900
+155% +$408K ﹤0.01% 5615
2022
Q4
$235K Sell
3,800
-1,000
-21% -$53.2K ﹤0.01% 7418
2022
Q3
$200K Buy
+4,800
New +$209K ﹤0.01% 8182
2022
Q1
Sell
-23,600
Closed -$452K 11025
2021
Q4
$452K Buy
23,600
+1,300
+6% +$32.6K ﹤0.01% 7453
2021
Q3
$738K Buy
22,300
+200
+0.9% +$6.11K ﹤0.01% 6536
2021
Q2
$733K Buy
+22,100
New +$613K ﹤0.01% 6497

Other funds holding TMDX

Jane Street's TMDX Position: Q4 2025 in Review

Jane Street sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 78,156 shares — an estimated $9.81M sold.

Jane Street first reported a position in TMDX in Q3 2020 and held it in 18 quarters. The position peaked at $27M in Q2 2025. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

  • Jane Street reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
  • Jane Street sold 78,156 Transmedics shares in Q4 2025, an estimated $9.81M.
  • Jane Street first reported a position in Transmedics in Q3 2020 and held it in 18 quarters.
  • Jane Street's Transmedics position peaked at $27M in Q2 2025.
  • 428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.